ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,726Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 457

$1.5M Total Retail Price of All Prescriptions

Rank: 3 out of 457

951 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 951 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

8% of this provider’s 951 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 11,253 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$85 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
CLOPIDOGREL 884 647 1 10
CRESTOR 658 424 2 14
AMLODIPINE BESYLATE 563 390 3 6
PLAVIX 538 390 4 12
PRAVASTATIN SODIUM 482 387 5 13
ATENOLOL 477 313 6 17
BYSTOLIC 467 352 7 32
PANTOPRAZOLE SODIUM 447 241 8 34
OMEPRAZOLE 348 217 9 25
TORSEMIDE 331 182 10 46
BISOPROLOL FUMARATE 323 273 11 50
DILTIAZEM 24HR CD 320 218 12 23
OXYCODONE HCL-ACETAMINOPHEN 312 86 S2 13 93
ISOSORBIDE MONONITRATE ER 312 204 13 9
SIMVASTATIN 302 281 15 7
FUROSEMIDE 290 200 16 5
POTASSIUM CHLORIDE 266 169 17 20
SOTALOL 253 221 18 27
RANEXA 244 97 19 38
LISINOPRIL 242 173 20 3
EFFIENT 229 107 21 48
KLOR-CON 10 204 145 22 72
DEXILANT 192 79 23 111
NITROGLYCERIN PATCH 191 172 24 59
HYDROCODONE-ACETAMINOPHEN 185 93 S3 25 45
ATORVASTATIN CALCIUM 180 140 26 11
NITROSTAT 179 113 27 21
METOPROLOL SUCCINATE 176 140 28 1
NEXIUM 171 73 29 55
AMIODARONE HCL 171 128 29 24
RANITIDINE HCL 171 110 29 80
WARFARIN SODIUM 171 141 29 8
DILTIAZEM ER 162 95 33 44
AMLODIPINE BESYLATE-BENAZEPRIL 155 137 34 65
TRICOR 140 77 35 99
DIGOXIN 135 109 36 15
NIASPAN 133 89 37 37
FENOFIBRATE 132 86 38 56
METOPROLOL TARTRATE 126 81 39 4
PREDNISONE 119 53 40 77
SPIRIVA 118 69 41 112
DOXYCYCLINE HYCLATE 117 64 42 160
GEMFIBROZIL 115 96 43 162
METFORMIN HCL 106 57 44 42
ENDOCET 106 31 S2 44 164
DILTIAZEM 24HR ER 105 50 46 29
BUMETANIDE 104 56 47 67
HYDROCHLOROTHIAZIDE 101 78 48 18
FLUTICASONE PROPIONATE 101 60 48 166
PACERONE 99 80 50 104
LEVOTHYROXINE SODIUM 96 55 51 33
MULTAQ 86 66 52 57
SIMCOR 85 37 53 146
KLOR-CON M20 85 40 53 35
METRONIDAZOLE 83 39 55 171
ALLOPURINOL 83 60 55 52
PROMETHAZINE HCL 83 31 R 55 117
LOSARTAN POTASSIUM 83 63 55 16
OXYCODONE-ACETAMINOPHEN 82 45 S2 59 172
CLONIDINE HCL 79 42 60 49
CARVEDILOL 79 40 60 2
OXYCODONE HCL 78 29 S2 62 73
TRAMADOL HCL 76 58 63 69
ZOLPIDEM TARTRATE 73 61 64 51
COLCRYS 73 49 64 108
VENTOLIN HFA 72 23 66 177
ESCITALOPRAM OXALATE 70 44 67 178
CYMBALTA 69 22 68 126
KLOR-CON M10 68 45 69 90
CITALOPRAM HBR 66 34 70 82
GABAPENTIN 63 37 71 60
HYDRALAZINE HCL 62 56 72 28
DIOVAN HCT 62 40 72 61
CYCLOBENZAPRINE HCL 60 17 R 74 123
DIOVAN 58 26 75 30
PROPAFENONE HCL 58 58 75 43
COMBIVENT 55 40 77 150
TOPIRAMATE 53 0 78 199
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 25 78 40
EXFORGE HCT 52 49 80 131
TAMSULOSIN HCL 51 41 81 88
EXFORGE 51 25 81 134
CLINDAMYCIN HCL 50 25 83 207
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.